Hospice Quality Score Assessment Post Pharmacist Intervention

Tabula Rasa HealthCare

Status: Withdrawn

Conditions: Respiratory Disease; Cardiovascular Diseases; Cancer; Dementia; Neurologic Disorder

Treatments: Other: Medication safety review

Study type: Observational

Funder types: Industry

Identifiers

NCT04361669

TRHC_RD_Hospice_2020

Details and patient eligibility

About

The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.

Full description

The objective of this study is evaluate a program at a hospice involving activities designed to improve the site's National Quality Forum (NQF) and Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores. These scores are calculated by the hospice using existing patient satisfaction survey scores (HCAHPS). The institution quantifies their compliance with national quality metrics (NQF) and reports this existing data to the pharmacist providing counseling services to their patients. The pharmacist assesses for areas for improvement and provides additional counseling services to improve the continuity and quality of care. The pilot program is scheduled to launch April 2020 and the researchers will look to assess for changes in the NQF scores, HCAHPS scores, and time for their partnering pharmacy to refill the first set of prescriptions.

Sex: All

Ages: 18 to 88 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Adult patients who were referred to hospice by a healthcare provider

Exclusion criteria

Patients 89 years or older

Trial design

0 participants in 2 patient groups

Intervention

Description:

Patients that receive pharmacist-delivered services in the pilot program

Treatment:

Other: Medication safety review

Control

Description:

Patients that do not receive pharmacist-delivered services in the pilot program

Treatment:

Other: Medication safety review